These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37182057)

  • 1. Five-Fraction Stereotactic Radiosurgery With Non-Contrast-Enhanced MRI-Based Target Definition and Moderate Dose Spillage Margin for Limited Brain Metastases With Impaired Renal Function.
    Ohtakara K; Suzuki K
    Cureus; 2023 Apr; 15(4):e37384. PubMed ID: 37182057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Extremely Inhomogeneous Gross Tumor Dose is Suitable for Volumetric Modulated Arc-Based Radiosurgery with a 5-mm Leaf-Width Multileaf Collimator for Single Brain Metastasis.
    Ohtakara K; Suzuki K
    Cureus; 2023 Feb; 15(2):e35467. PubMed ID: 36999102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Brain Metastasis Shrinking and Deviation During 10-Fraction Stereotactic Radiosurgery With Late Sequela: Suggesting Dose Ramification Between Tumor Eradication and Symptomatic Radionecrosis.
    Ohtakara K; Tanahashi K; Kamomae T; Miyata K; Suzuki K
    Cureus; 2023 Jan; 15(1):e33411. PubMed ID: 36751179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-Fraction Stereotactic Radiosurgery With Different Gross Tumor Doses and Inhomogeneities for Brain Metastasis of >10 cc: Treatment Responses Suggesting Suitable Biological Effective Dose Formula for Single and 10 Fractions.
    Ohtakara K; Nakabayashi K; Suzuki K
    Cureus; 2023 Feb; 15(2):e34636. PubMed ID: 36895545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Dynamic Conformal Arcs With Forward Planning for Radiosurgery of Small Brain Metastasis: Each Double Arc and Different To-and-Fro Leaf Margins to Optimize Dose Gradient Inside and Outside the Gross Tumor Boundary.
    Ohtakara K; Suzuki K
    Cureus; 2023 Feb; 15(2):e34831. PubMed ID: 36919061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-Year Sustained Complete Remission With Minimal Adverse Effects Following Radiosurgery for 2-cm Brain Metastasis With Deep Eloquent Location From Lung Adenocarcinoma Despite Low Marginal Dose and High 12 Gy Volume.
    Ohtakara K; Nakao M; Muramatsu H; Suzuki K
    Cureus; 2023 Mar; 15(3):e36680. PubMed ID: 37113354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gradual and Remarkable Tumor Shrinkage Following Seven-Fraction Stereotactic Radiosurgery Alone With a Marginal Dose of 48.3 Gy for Large Lobar Possibly Intra-sulcal Brain Metastasis From Renal Cell Carcinoma.
    Ohtakara K; Aoki S; Tajima M; Ohno T; Suzuki K
    Cureus; 2023 Mar; 15(3):e36346. PubMed ID: 37082500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
    J Neurosurg; 2019 Mar; 130(3):797-803. PubMed ID: 29676690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric Study of Automatic Brain Metastases Planning in Comparison with Conventional Multi-Isocenter Dynamic Conformal Arc Therapy and Gamma Knife Radiosurgery for Multiple Brain Metastases.
    Mori Y; Kaneda N; Hagiwara M; Ishiguchi T
    Cureus; 2016 Nov; 8(11):e882. PubMed ID: 28003946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
    Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.
    Kocher M; Wittig A; Piroth MD; Treuer H; Seegenschmiedt H; Ruge M; Grosu AL; Guckenberger M
    Strahlenther Onkol; 2014 Jun; 190(6):521-32. PubMed ID: 24715242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy.
    Uto M; Ogura K; Katagiri T; Takehana K; Mizowaki T
    Radiat Oncol; 2021 Jul; 16(1):140. PubMed ID: 34321033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of treatment isocenter location in single-isocenter LINAC-based stereotactic radiosurgery for management of multiple brain metastases.
    Cui T; Zhou Y; Yue NJ; Vergalasova I; Zhang Y; Zhu J; Nie K
    Med Phys; 2021 Dec; 48(12):7632-7640. PubMed ID: 34655249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform.
    Wu CC; Chaudhary KR; Na YH; Welch D; Black PJ; Sonabend AM; Canoll P; Saenger YM; Wang TJC; Wuu CS; Hei TK; Cheng SK
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):191-201. PubMed ID: 28816146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.
    Prabhu RS; Miller KR; Asher AL; Heinzerling JH; Moeller BJ; Lankford SP; McCammon RJ; Fasola CE; Patel KR; Press RH; Sumrall AL; Ward MC; Burri SH
    J Neurosurg; 2019 Nov; 131(5):1387-1394. PubMed ID: 30554174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
    Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
    Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Incidence and Its Associated Factors Relevant to Brain Radionecrosis That Requires Intervention Following Single or Fractionated Stereotactic Radiosurgery Using Vero4DRT for Brain Metastases.
    Yamada T; Ohtakara K; Kamomae T; Itoh J; Shimada H; Ishihara S; Naganawa S
    Cureus; 2022 Jun; 14(6):e25888. PubMed ID: 35844334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
    Yamada Y; Katsoulakis E; Laufer I; Lovelock M; Barzilai O; McLaughlin LA; Zhang Z; Schmitt AM; Higginson DS; Lis E; Zelefsky MJ; Mechalakos J; Bilsky MH
    Neurosurg Focus; 2017 Jan; 42(1):E6. PubMed ID: 28041329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of radiation dose spillage from the Gamma Knife Perfexion with that from volumetric modulated arc radiosurgery during treatment of multiple brain metastases in a single fraction.
    McDonald D; Schuler J; Takacs I; Peng J; Jenrette J; Vanek K
    J Neurosurg; 2014 Dec; 121 Suppl():51-9. PubMed ID: 25434937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.